Target intelligence / Profile preview

RNA, U6 small nuclear 741, pseudogene (RNU6-741P)

Target
RNU6-741P
Molecular classification
Other, Processed pseudogene, non-coding RNA pseudogene
01

Overview

RNU6-741P is a processed pseudogene derived from the U6 small nuclear RNA gene, a core component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[1][3]. As a pseudogene, RNU6-741P does not produce a functional RNA molecule or protein and is generally considered noncoding and nonfunctional. While functional U6 snRNA is essential for spliceosome activity, most U6-derived pseudogenes, including RNU6-741P, are retrotransposed genomic elements lacking regulatory or protein-coding capability[1][3]. There is no evidence or clinical indication that RNU6-741P is involved in human disease as a molecular target, biomarker, or therapeutic agent[2][3]. Pseudogenes like RNU6-741P can sometimes exert regulatory functions at the RNA level, but no evidence for such a role exists for this specific pseudogene[2]. U6 snRNA, the parent molecule, is well-studied and plays an essential role in splicing; pseudogenes derived from U6 snRNA (including RNU6-741P) typically do not retain this function[1][3]. Pseudogenes broadly may influence disease by regulating parental gene expression (e.g., through antisense interference or acting as “decoys” for microRNAs), but this has not been specifically described for RNU6-741P[2]. In summary, RNU6-741P is not a drug target or functional receptor/enzyme/transporter, but a genomic pseudogene with no direct therapeutic or biological relevance[1][3].

Other names
RNU6-741PU6 snRNA pseudogene 741
02

Biological functions

Otherno known direct biological function; pseudogene roles are usually regulatory or nonfunctional
03

Disease associations

Otherpseudogenes can participate in gene regulation, but no direct, specific disease relevance reported for RNU6-741P

Beyond the preview

Go deeper on RNA, U6 small nuclear 741, pseudogene (RNU6-741P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 741, pseudogene (RNU6-741P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call